Journal: PLoS ONE
Article Title: Integrated Proteomic Analysis of Human Cancer Cells and Plasma from Tumor Bearing Mice for Ovarian Cancer Biomarker Discovery
doi: 10.1371/journal.pone.0007916
Figure Lengend Snippet: Protein levels of TIMP1, LCN2, PFN1, IGFBP2, SPARC, EEF1B2 and CLU were determined from the following: (A) normal ovarian tissue (N) and ovarian tumors (T) isolated from the K-ras/Pten, or (B) Pten/Apc mouse model of ovarian cancer, (C) conditioned media (CM) from normal human surface epithelium cells lines (HOSE) and ovarian cancer cell lines and (D) human primary tissues (HPT): normal ovarian tissue (N) and ovarian tumors (T). For mouse preparations, tissue lysates were prepared from normal ovaries and tumors taken from the same animal (a–d) along with four-five tumors from separate animals (e–i). For human primary tumor (HPT) samples, tissue lysates were prepared from 4 tumor samples paired with their respective normal tissue from the same patient and 3 lone tumor samples, in which no normal samples were available. Patient samples are as follows: patient #14 had independent bilateral serous borderline tumors in the left (TL) and right ovary (TR), tumors #3, #7, and #15 are papillary serous carcinomas, tumor #12 is an epithelial borderline tumor of the Müllerian-type, with endocervical mucinous and serous differentiation, tumor #13 is clear cell carcinoma, and tumor #16 is endometrioid adenocarcinoma.
Article Snippet: Timp1 concentrations in murine plasma were measured using a Quanitikine-Mouse Timp1 ELISA Kit, while mouse Lcn2 levels were detected with a DuoSet ELISA Kit (R&D Systems, Minneapolis, MN USA).
Techniques: Isolation